Hexosaminidase A/HEXA Antibody (20F1) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-42629DL594
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Western Blot
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Mouse IgG2a Lambda Clone # 20F1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human Hexosaminidase A/HEXA (89-529aa) purified from E. coli
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Lambda
Applications for Hexosaminidase A/HEXA Antibody (20F1) [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Hexosaminidase A/HEXA
Alternate Names
HEXA, TSD
Gene Symbol
HEXA
Additional Hexosaminidase A/HEXA Products
Product Documents for Hexosaminidase A/HEXA Antibody (20F1) [DyLight 594]
Product Specific Notices for Hexosaminidase A/HEXA Antibody (20F1) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...